Inventor · disambiguated record
James Aaron Balog
Also filed as: BALOG JAMES AARON · BALOG James
57 granted patents·12 pending applications·193 citations·filing 2001–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO52FLEXUS BIOSCIENCES INC7VELAPARTHI UPENDER2AEGIS BIOSCIENCES LLC1AUSTIN JOEL FRANCIS1
Top patents by PatentIndex Score
69 records- 0196US9643972B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted May 9, 2017·15 cites·47 claims
- 0296US9598422B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2015·Granted Mar 21, 2017·21 cites·34 claims
- 0394US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0493US10106546B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2017·Granted Oct 23, 2018·6 cites·66 claims
- 0590US7141578B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·17 cites·14 claims
- 0690US7001911B2Fused cyclic modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 21, 2006·31 cites·21 claims
- 0789US10533014B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·3 cites·20 claims
- 0888US10959986B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 30, 2021·3 cites·42 claims
- 0986US10633342B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·2 cites·17 claims
- 1085US11066383B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 20, 2021·3 cites·15 claims
- 1183US11548870B2Compounds useful as inhibitors of helios proteinBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 10, 2023·1 cites·12 claims
- 1283US10696648B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 30, 2020·3 cites·20 claims
- 1383US10399933B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1482US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1582US9675571B2Inhibitors of indoleamine 2,3-dioxygenase (IDO)BRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 13, 2017·6 cites·11 claims
- 1682US7517904B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·1 cites·3 claims
- 1781US9133139B2Fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·2 cites·10 claims
- 1881US7655688B2Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 2, 2010·5 cites·8 claims
- 1981US7235563B2Spirocyclic compounds useful as modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 26, 2007·3 cites·9 claims
- 2080US11253525B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 22, 2022·1 cites·32 claims
- 2179US11351164B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 7, 2022·1 cites·17 claims
- 2278US9765018B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 19, 2017·4 cites·11 claims
- 2378US9758492B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 12, 2017·4 cites·11 claims
- 2478US7776859B2Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 17, 2010·2 cites·17 claims
- 2578US7550458B2Tricycloundecane compounds useful as modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 23, 2009·2 cites·11 claims
- 2678US7432267B2Fused cyclic modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 7, 2008·2 cites·14 claims
- 2777US12331045B2Substituted phenyl oxazolone compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Jun 17, 2025·0 cites·27 claims
- 2877US11649212B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 16, 2023·1 cites·4 claims
- 2977US10689331B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 23, 2020·2 cites·17 claims
- 3077US7087636B2Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 8, 2006·9 cites·25 claims
- 3176US12145927B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 19, 2024·1 cites·11 claims
- 3276US9624188B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 18, 2017·3 cites·11 claims
- 3376US8969586B2Substituted bicyclic heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Mar 3, 2015·2 cites·6 claims
- 3475US10544099B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 28, 2020·1 cites·18 claims
- 3575US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 3674US11447449B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·1 cites·9 claims
- 3774US11337970B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 24, 2022·1 cites·5 claims
- 3874US9895330B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 20, 2018·2 cites·10 claims
- 3974US9145419B2Imidazopyridazinyl compoundsVELAPARTHI UPENDER·Filed 2011·Granted Sep 29, 2015·3 cites·8 claims
- 4074US7655689B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 2, 2010·1 cites·13 claims
- 4173US2024376082A1Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 4272US11718601B2Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 8, 2023·0 cites·39 claims
- 4372US2023303527A1Pyridinyl substituted oxoisoindoline compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 4468US2008214643A1Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 4568US2022305144A1Radioligands for imaging the id01 enzymeBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4667US8916553B2Sulfonamide compounds useful as CYP17 inhibitorsAUSTIN JOEL FRANCIS·Filed 2011·Granted Dec 23, 2014·2 cites·14 claims
- 4767US2025145590A1Ubiquitin specific processing protease 1 (usp1) compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 4866US11932601B2Immunoregulatory agentsFLEXUS BIOSCIENCES INC·Filed 2021·Granted Mar 19, 2024·0 cites·17 claims
- 4959US9598436B2Substituted bicyclic heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 21, 2017·0 cites·8 claims
- 5059US2025346574A1Pyridinyl substituted oxoisoindoline compounds for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →